These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28945660)

  • 1. Hormone Therapy and Venous Thromboembolism in a Transgender Adolescent.
    Stanley K; Cooper J
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e38-e40. PubMed ID: 28945660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous Thromboembolism in a Transgender Adolescent on Testosterone Therapy: A Case Report and Literature Review.
    Fan EM; Gordner C; Luty J
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e352-e354. PubMed ID: 32079984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy.
    Nota NM; Wiepjes CM; de Blok CJM; Gooren LJG; Kreukels BPC; den Heijer M
    Circulation; 2019 Mar; 139(11):1461-1462. PubMed ID: 30776252
    [No Abstract]   [Full Text] [Related]  

  • 4. Affirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event.
    Penney SW; Jung JH; Ballantyne AJ; Parekh DS; Klein DA; Viola SA
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):e892-e895. PubMed ID: 35293883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism peaking 3 months after starting testosterone therapy: testosterone-thrombophilia interactions.
    Glueck CJ; Goldenberg N; Wang P
    J Investig Med; 2018 Apr; 66(4):733-738. PubMed ID: 29248890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
    Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
    Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.
    Kotamarti VS; Greige N; Heiman AJ; Patel A; Ricci JA
    J Sex Med; 2021 Jul; 18(7):1280-1291. PubMed ID: 34140253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia in 67 Patients With Thrombotic Events After Starting Testosterone Therapy.
    Glueck CJ; Prince M; Patel N; Patel J; Shah P; Mehta N; Wang P
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):548-53. PubMed ID: 26620418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone, thrombophilia, thrombosis.
    Freedman J; Glueck CJ; Prince M; Riaz R; Wang P
    Transl Res; 2015 May; 165(5):537-48. PubMed ID: 25639953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Getahun D; Nash R; Flanders WD; Baird TC; Becerra-Culqui TA; Cromwell L; Hunkeler E; Lash TL; Millman A; Quinn VP; Robinson B; Roblin D; Silverberg MJ; Safer J; Slovis J; Tangpricha V; Goodman M
    Ann Intern Med; 2018 Aug; 169(4):205-213. PubMed ID: 29987313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications.
    Hontscharuk R; Alba B; Manno C; Pine E; Deutsch MB; Coon D; Schechter L
    Plast Reconstr Surg; 2021 Apr; 147(4):1008-1017. PubMed ID: 33776045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism.
    Stevens SM; Ansell JE
    Semin Respir Crit Care Med; 2017 Feb; 38(1):107-120. PubMed ID: 28208204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients: A Systematic Review.
    Boskey ER; Taghinia AH; Ganor O
    JAMA Surg; 2019 Feb; 154(2):159-169. PubMed ID: 30516808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance.
    Bourgeois AL; Auriche P; Palmaro A; Montastruc JL; Bagheri H
    Ann Endocrinol (Paris); 2016 Feb; 77(1):14-21. PubMed ID: 26830952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor from Blasdel et al: "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-affirming Surgery".
    Blasdel G; Shakir N; Parker A; Bluebond-Langner R; Zhao L
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3783-e3784. PubMed ID: 33846750
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Letter to the Editor from Blasdel et al: "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender Affirming Surgery".
    Kozato A; Safer JD; Pang JH
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3791. PubMed ID: 33846741
    [No Abstract]   [Full Text] [Related]  

  • 18. METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS.
    Fernandez JD; Tannock LR
    Endocr Pract; 2016 Apr; 22(4):383-8. PubMed ID: 26574790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy for transgender men.
    Irwig MS
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):301-311. PubMed ID: 27084565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine.
    Le A; Huang KJ; Cirrincione LR
    Trends Pharmacol Sci; 2022 Jul; 43(7):582-592. PubMed ID: 35487786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.